We hypothesize that direct activation of Akt through a potent small molecule like SC79, possibly delivered to the airway through a nebulizer or nasal spray, may have protective pro-survival, antioxidant, and/or anti-inflammatory effects against viral infection or bacteria susceptible to NO (e.g., Pseudomonas infections in CF). Here, AKT1 is linked to Pseudomonas infection.